A Trial of Vitamins and HAART in HIV Disease Progression

PHASE3CompletedINTERVENTIONAL
Enrollment

4,012

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
HIV Infections
Interventions
DIETARY_SUPPLEMENT

Multivitamins (including B, C and E)

One daily oral dose of 20 mg B1, 20 mg B2, 25 mg B6, 100 mg niacin, 50 μg B12, 0.8 mg folic acid, 500 mg C, and 30 mg vitamin E taken taken from randomization until the end of follow-up (24-28 months).

DIETARY_SUPPLEMENT

Multivitamins B, C and E

One daily oral dose of 1.2 mg vitamin B1, 1.2 mg vitamin B2, 1.3 mg vitamin B6, 15 mg niacin, 2.4 μg vitamin B12, 0.4 mg folic acid, 80 mg vitamin C, and 15 mg vitamin E taken taken from randomization until the end of follow-up (24-28 months).

Trial Locations (1)

Unknown

Muhimbili University College of Health Sciences, Dar es Salaam

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Harvard School of Public Health (HSPH)

OTHER

NCT00383669 - A Trial of Vitamins and HAART in HIV Disease Progression | Biotech Hunter | Biotech Hunter